{ "access": { "embargo": { "active": false, "reason": null }, "files": "public", "record": "public", "status": "open" }, "created": "2021-03-27T07:18:40.505020+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "files": { "count": 1, "enabled": true, "entries": { "platelet.pdf": { "checksum": "md5:7b973fbb38403cc0e35a6de98f54a92b", "ext": "pdf", "id": "5aee6115-b5a1-4aa3-a0d7-73a822f176c7", "key": "platelet.pdf", "metadata": null, "mimetype": "application/pdf", "size": 110629 } }, "order": [], "total_bytes": 110629 }, "id": "4641693", "is_draft": false, "is_published": true, "links": { "access": "https://zenodo.org/api/records/4641693/access", "access_links": "https://zenodo.org/api/records/4641693/access/links", "access_request": "https://zenodo.org/api/records/4641693/access/request", "access_users": "https://zenodo.org/api/records/4641693/access/users", "archive": "https://zenodo.org/api/records/4641693/files-archive", "archive_media": "https://zenodo.org/api/records/4641693/media-files-archive", "communities": "https://zenodo.org/api/records/4641693/communities", "communities-suggestions": "https://zenodo.org/api/records/4641693/communities-suggestions", "doi": "https://doi.org/10.5281/zenodo.4641693", "draft": "https://zenodo.org/api/records/4641693/draft", "files": "https://zenodo.org/api/records/4641693/files", "latest": "https://zenodo.org/api/records/4641693/versions/latest", "latest_html": "https://zenodo.org/records/4641693/latest", "media_files": "https://zenodo.org/api/records/4641693/media-files", "parent": "https://zenodo.org/api/records/4641692", "parent_doi": "https://zenodo.org/doi/10.5281/zenodo.4641692", "parent_html": "https://zenodo.org/records/4641692", "requests": "https://zenodo.org/api/records/4641693/requests", "reserve_doi": "https://zenodo.org/api/records/4641693/draft/pids/doi", "self": "https://zenodo.org/api/records/4641693", "self_doi": "https://zenodo.org/doi/10.5281/zenodo.4641693", "self_html": "https://zenodo.org/records/4641693", "self_iiif_manifest": "https://zenodo.org/api/iiif/record:4641693/manifest", "self_iiif_sequence": "https://zenodo.org/api/iiif/record:4641693/sequence/default", "versions": "https://zenodo.org/api/records/4641693/versions" }, "media_files": { "count": 0, "enabled": false, "entries": {}, "order": [], "total_bytes": 0 }, "metadata": { "creators": [ { "affiliations": [ { "name": "Independent" } ], "person_or_org": { "family_name": "Arumugham", "given_name": "Vinu", "identifiers": [ { "identifier": "0000-0003-1047-1626", "scheme": "orcid" } ], "name": "Arumugham, Vinu", "type": "personal" } } ], "description": "
SARS-CoV-2 mRNA vaccines and a viral vector based vaccine have been authorized for use in the US.
\nAstraZeneca’s viral vector based vaccines have been authorized for use in many European countries.
\nNumerous cases of bleeding disorders have been reported following SARS-CoV-2 vaccine
\nadministration. Vaccine Adverse Event Reporting System (VAERS) in the US shows 200 cases of
\nplatelet disorders following the vaccines. Such cases have also been investigated in Europe following
\nAstraZeneca vaccine administration. Prof. Pål Andre Holme of the Oslo University Hospital and Prof.
\nAndreas Greinacher at the University of Greifswald have independently found evidence for this being a
\nvaccine induced autoimmune disorder. Greinacher and others identified platelet factor 4 (PF4) as the
\ntarget of autoantibodies induced by the vaccine. Greinacher’s team have named it vaccine-induced
\nprothrombotic immune thrombocytopenia (VIPIT).
\nAnimal/plant/fungal/viral protein contamination of vaccines and the risk of them inducing autoimmune
\ndiseases was predicted and world vaccine regulatory bodies were all repeatedly warned of the dangers.
\nSafety engineering processes such as design Failure Modes and Effects Analysis (FMEA) are still being
\nignored in the vaccine industry ten years after the Pandemrix induced narcolepsy disaster.
\nWe show plant proteins that contaminate the vaccines have high protein sequence homology to epitopes
\nknown to be involved in thrombocytopenia, using Immune Epitope Database (IEDB) data and
\nBLASTP bioinformatics analysis. BLASTP match score range is 27.8-19.6. The score for the epitope
\ninvolved in Pandemrix induced narcolepsy was 19.7, in comparison. The conditions required for
\ninducing autoimmunity are immunization using homologous xeneogeneic antigens that are similar to
\nself antigens (plant proteins in this case) and costimulation of the innate immune system either by the
\nadenovirus, lipid-in-water emulsion or the mRNA in the vaccines acting as adjuvants.
\nBleeding disorders are just the latest of numerous vaccine-induced diseases. For every individual
\ndiagnosed with VIPIT, thousands will develop subclinical disease. Of course, VIPIT is not the only
\nautoimmune disorder induced by these contaminants.
\n